-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Maintains Neutral on Agilon Health, Raises Price Target to $5

Benzinga·05/08/2025 14:49:18
Listen to the news
Goldman Sachs analyst Jamie Perse maintains Agilon Health (NYSE:AGL) with a Neutral and raises the price target from $2.5 to $5.